Novartis has reported positive top-line results from the phase 3 KALUMA trial evaluating KLU156 (ganaplacide/lumefantrine, or ...

Merck (known as MSD outside the US and Canada) has entered into a definitive agreement to acquire Cidara Therapeutics, a ...

Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, ...

PMEA returned on 19 November to the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Johnson & Johnson (J&J) has received a positive recommendation from the UK’s National Institute for Health and Care ...

VML Portugal has announced the launch of VML Health, with pharma communications veteran Mariana Marta dos Santos being ...

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional ...

The career path of a Nurse Practitioner is often envisioned as a straight line: clinical practice, specialization, perhaps a ...

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as ...

Biogen and Eisai have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an ...

Gilead has reported that its phase 3 ASCENT-07 trial evaluating Trodelvy (sacituzumab govitecan-hziy) as a first-line ...

Newark, NJ - - Medscape, the leading digital platform for physicians and healthcare professionals (HCPs), has been awarded a 2025 Silver Anthem Award for ...